Dah-Shyong Yu Selected Research

Dah-Shyong Yu Research Topics

Disease

33	Neoplasms (Cancer) 02/2022 - 01/2002
18	Urinary Bladder Neoplasms (Bladder Cancer) 03/2023 - 01/2002
8	Carcinoma (Carcinomatosis) 02/2022 - 11/2003
8	Prostatic Neoplasms (Prostate Cancer) 10/2014 - 11/2003
6	Carcinogenesis 02/2022 - 01/2002
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 02/2009
6	Transitional Cell Carcinoma 07/2013 - 01/2002
4	Circulating Neoplastic Cells 03/2023 - 01/2021
4	Neoplasm Metastasis (Metastasis) 02/2022 - 04/2012
4	Lower Urinary Tract Symptoms 10/2019 - 10/2009
3	Disease Progression 03/2023 - 05/2014
3	Hemorrhage 03/2022 - 04/2006
3	Cystitis 10/2019 - 09/2011
3	Kidney Neoplasms (Kidney Cancer) 09/2015 - 02/2009
2	Inflammation (Inflammations) 08/2020 - 03/2015
2	Lung Neoplasms (Lung Cancer) 01/2013 - 09/2003
2	Adenocarcinoma 11/2012 - 06/2012
1	Fever (Fevers) 03/2022
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 10/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2021
1	Pain (Aches) 01/2021
1	Nocturia 10/2019
1	Non-Muscle Invasive Bladder Neoplasms 07/2019
1	Inguinal Hernia (Direct Inguinal Hernia) 09/2018
1	Urologic Neoplasms (Urological Cancer) 01/2018
1	Peritoneal Neoplasms 02/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2015
1	Pathologic Constriction (Stenosis) 08/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2014
1	Infections 08/2014
1	Retroperitoneal Fibrosis 08/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 02/2022 - 05/2005
6	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 01/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 04/2012
4	Hormones (Hormone)IBA 01/2013 - 05/2005
3	PhytochemicalsIBA 04/2021 - 12/2019
3	Gemcitabine FDA Link 04/2021 - 12/2019
3	CateninsIBA 01/2020 - 01/2012
3	Ketamine FDA LinkGeneric 10/2019 - 09/2011
3	Sunitinib (Sutent)FDA Link 08/2014 - 04/2012
3	CytokinesIBA 02/2007 - 03/2004
3	VaccinesIBA 02/2007 - 03/2004
3	Interferon-gamma (Interferon, gamma)IBA 02/2007 - 03/2004
3	DNA VaccinesIBA 03/2004 - 03/2004
2	LigandsIBA 01/2022 - 07/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 07/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Coloring Agents (Dyes)IBA 02/2017 - 01/2017
2	Prostate-Specific Antigen (Semenogelase)IBA 10/2014 - 01/2013
2	Histone Deacetylase InhibitorsIBA 01/2013 - 02/2009
2	PanobinostatIBA 01/2013 - 02/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2012 - 04/2012
2	AcetoneIBA 08/2004 - 09/2003
2	Interleukin-12 (IL 12)IBA 03/2004 - 03/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2004 - 01/2003
1	Hemoglobins (Hemoglobin)IBA 03/2022
1	Competitive Endogenous RNAIBA 02/2022
1	Long Noncoding RNAIBA 02/2022
1	Inhibins (Inhibin)IBA 02/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Ellagic AcidIBA 04/2021
1	Capsaicin (Zostrix)FDA Link 02/2021
1	Interleukin-6 (Interleukin 6)IBA 08/2020
1	Interleukin-8 (Interleukin 8)IBA 08/2020
1	ResveratrolIBA 12/2019
1	CurcuminIBA 12/2019
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 07/2019
1	Niclosamide FDA Link 01/2018
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2017
1	Cadherins (E-Cadherin)IBA 05/2016
1	MicroRNAs (MicroRNA)IBA 05/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015
1	Small Interfering RNA (siRNA)IBA 09/2015
1	Toll-Like Receptor 7IBA 08/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2015
1	Tissue Inhibitor of Metalloproteinase-3IBA 03/2015
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 03/2015
1	Fatty Acid-Binding ProteinsIBA 03/2015
1	Histones (Histone)IBA 03/2015
1	Emodin (Archin)IBA 03/2015
1	Collagen Type VIIIIBA 03/2015
1	Carrier Proteins (Binding Protein)IBA 03/2015
1	anthra(2,1- c)(1,2,5)thiadiazole- 6,11- dioneIBA 11/2014
1	Capsules (Microcapsules)IBA 10/2014

Therapy/Procedure

8	Therapeutics 12/2022 - 03/2004
6	Immunotherapy 01/2022 - 03/2004
3	Cystectomy 03/2023 - 11/2012
2	Neoadjuvant Therapy 03/2023 - 11/2012
2	Operative Time 03/2022 - 01/2021
2	Nephroureterectomy 02/2022 - 01/2021
2	Intravesical Administration 07/2019 - 10/2009
2	Prostatectomy (Retropubic Prostatectomy) 09/2018 - 10/2014
2	Drug Therapy (Chemotherapy) 11/2012 - 04/2012
1	Length of Stay 03/2022
1	Denervation 10/2021
1	Hysterectomy 10/2021
1	Laparotomy 12/2019
1	Adjuvant Chemotherapy 11/2014
1	Chemoradiotherapy 08/2014
1	Operative Surgical Procedures 08/2014